Michelle L Basil insider trades: Haemonetics (HAE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michelle reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 29, 2024 | HAE | ↓ Sell | 12,990 | $88.08 | $1.1M | Direct | May 29, 2024 (0d) |
| May 20, 2024 | HAE | ↓ Sell | 2,677 | $95.05 | $254K | Direct | May 21, 2024 (1d) |
| May 16, 2024 | HAE | ↓ Sell | 985 | $96.14 | $95K | Direct | May 17, 2024 (1d) |
| Oct 24, 2022 | HAE | ↓ Sell | 180 | $80.39 | $14K | Direct | Oct 26, 2022 (2d) |
| Sep 19, 2022 | HAE | ↓ Sell | 11,448 | $78.36 | $897K | Direct | Sep 21, 2022 (2d) |
| Sep 15, 2022 | HAE | ↓ Sell | 33,798 | $77.89 | $2.6M | Direct | Sep 19, 2022 (4d) |
| Jun 13, 2022 | HAE | ↓ Sell | 277 | $62.60 | $17K | Direct | Jun 15, 2022 (2d) |
| May 19, 2022 | HAE | ↓ Sell | 3,258 | $59.10 | $193K | Direct | May 23, 2022 (4d) |
| May 16, 2022 | HAE | ↓ Sell | 196 | $56.10 | $11K | Direct | May 18, 2022 (2d) |
| Oct 25, 2021 | HAE | ↓ Sell | 120 | $71.93 | $9K | Direct | Oct 27, 2021 (2d) |
| Jun 14, 2021 | HAE | ↓ Sell | 195 | $59.87 | $12K | Direct | Jun 16, 2021 (2d) |
| Jun 7, 2021 | HAE | ↓ Sell | 442 | $55.09 | $24K | Direct | Jun 9, 2021 (2d) |
| May 19, 2021 | HAE | ↓ Sell | 220 | $55.19 | $12K | Direct | May 20, 2021 (1d) |
| May 17, 2021 | HAE | ↓ Sell | 204 | $55.97 | $11K | Direct | May 18, 2021 (1d) |
| Mar 8, 2021 | HAE | ↓ Sell | 385 | $120.07 | $46K | Direct | Mar 10, 2021 (2d) |
| Oct 23, 2020 | HAE | ↓ Sell | 181 | $106.58 | $19K | Direct | Oct 26, 2020 (3d) |
| Jun 16, 2020 | HAE | ↓ Sell | 24,217 | $89.56 | $2.2M | Direct | Jun 16, 2020 (0d) |
| Jun 8, 2020 | HAE | ↓ Sell | 687 | $97.03 | $67K | Direct | Jun 10, 2020 (2d) |
| May 15, 2020 | HAE | ↓ Sell | 203 | $100.44 | $20K | Direct | May 19, 2020 (4d) |
| Mar 9, 2020 | HAE | ↓ Sell | 395 | $98.00 | $39K | Direct | Mar 10, 2020 (1d) |
| Oct 9, 2019 | HAE | ↓ Sell | 19,516 | $123.23 | $2.4M | Direct | Oct 10, 2019 (1d) |
| Jun 12, 2019 | HAE | ↓ Sell | 231 | $109.37 | $25K | Direct | Jun 13, 2019 (1d) |
| Jun 7, 2019 | HAE | ↓ Sell | 13,335 | $103.38 | $1.4M | Direct | Jun 10, 2019 (3d) |
| Mar 7, 2019 | HAE | ↓ Sell | 391 | $83.57 | $33K | Direct | Mar 11, 2019 (4d) |
| Jun 7, 2018 | HAE | ↓ Sell | 457 | $92.73 | $42K | Direct | Jun 8, 2018 (1d) |
| Mar 6, 2018 | HAE | ↓ Sell | 389 | $72.23 | $28K | Direct | Mar 8, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HAE insiders
Open-market trades in the last 12 months
About Michelle L Basil's insider trades
Michelle L Basil is EVP and General Counsel at Haemonetics (HAE). Since Mar 6, 2018, Michelle has reported no open-market purchases and 26 sales worth $11.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), shares withheld for taxes (10 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HAE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.